Anhui Anke Biotechnology Group Co Ltd (300009.SZ)

300009.SZ on Shenzhen Stock Exchange

27 Nov 2015
Change (% chg)

¥-0.89 (-2.47%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for 300009.SZ


ANHUI ANKE BIOTECHNOLOGY (GROUP) CO., LTD. is principally engaged in the research, development, manufacture and distribution of biological products, Chinese medicines and synthetic drugs. Its biological products include recombinant human interferon alfa-2b injection, recombinant human interferon alfa-2b suppository, recombinant... (more)


Beta: 0.79
Market Cap(Mil.): ¥13,246.00
Shares Outstanding(Mil.): 377.38
Dividend: --
Yield (%): 0.33


  300009.SZ Industry Sector
P/E (TTM): 96.01 36.96 34.31
EPS (TTM): 0.37 -- --
ROI: 17.31 -4.40 14.77
ROE: 17.90 -5.13 15.97
Search Stocks

BRIEF-Anhui Anke Biotechnology gets regulatory approval to acquire assets

* Says gets securities regulator's approval to acquire assets, shares to resume trade on Sept 16

15 Sep 2015

BRIEF-Anhui Anke Biotech plans to acquire stake in Jiangsu firm

* Says signs letter of intent to acquire a 25 percent stake in a Jiangsu biotech firm for up to 112.5 million yuan ($18.12 million)

13 Jul 2015

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider : Reuters Investment Profile
Provider : Thomson Reuters Stock Report
Provider : Sadif Analytics Prime

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks